Personensuche
Personensuche
Es wurde 1 Person gefunden.
WiWi / IBES
Anschrift
Weststadttürme, Berliner Platz 6-8
45127 Essen
45127 Essen
Raum
WST-B.09.04
Telefon
Webseite
Funktionen
-
Juniorprofessor/in, Juniorprofessur für empirische Gesundheitsökonomik
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
2023 WS
-
2022 WS
-
2022 SS
-
2021 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Insurance barriers and inequalities in health care access : Evidence from dual practiceIn: Health Economics Review Jg. 14 (2024) Nr. 1, 23Online Volltext: dx.doi.org/ (Open Access)
-
Policy as a strategy to innovate in health care? : A content analysis of innovation policies in Germany, 1994–2017In: The International Journal of Health Planning and Management Jg. 38 (2023) Nr. 6, S. 1657 - 1675Online Volltext: dx.doi.org/ (Open Access)
-
To Seek Program Accreditation, Innovation, or Both? : Examining the Interdependencies in High-Reliability Health Care OrganizationsIn: Schmalenbach Journal of Business Research (SBUR) Jg. 75 (2023) Nr. 3, S. 281 - 302Online Volltext: dx.doi.org/ (Open Access)
-
Virtueller Workshop der Arbeitsgruppe Ukraine der DGGÖ am 22. März 2023 zum Thema "Health and human capital in a disrupted transition economy"In: Gesundheitsökonomie & Qualitätsmanagement Jg. 28 (2023) Nr. 3, S. 120 - 121Online Volltext: dx.doi.org/
-
Availability of New Medicines in the US and Germany From 2004 to 2018In: JAMA Network Open Jg. 5 (2022) Nr. 8, e2229231Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? : A Retrospective Analysis of Switzerland 2015-2020In: Value in Health Jg. 25 (2022) Nr. 7, S. 1124 - 1132Online Volltext: dx.doi.org/ (Open Access)
-
The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in GermanyIn: Value in Health Jg. 25 (2022) Nr. 9, S. 1528 - 1538Online Volltext: dx.doi.org/
-
Do soft cost-control measures change productivity? : Preferred statin prescribing in Germany
81st Annual Meeting of the Academy of Management 2021: Bringing the Manager Back in Management, 29.07.-04.08.2021, Virtual,In: Academy of Management Proceedings (2021) 175912Online Volltext: dx.doi.org/ -
Regional innovation systems of medical technology : A knowledge production function of cardiovascular research and funding in europeIn: REGION: The Journal of ERSA Jg. 8 (2021) Nr. 2, S. 57 - 81Online Volltext: dx.doi.org/ (Open Access)
-
Are patients more adherent to newer drugs?In: Health Care Management Science Jg. 23 (2020) Nr. 4, S. 605 - 618Online Volltext: dx.doi.org/ (Open Access)
-
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in GermanyIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 17 (2020) Nr. 11, S. 4113Online Volltext: dx.doi.org/ (Open Access)
-
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in GermanyIn: Health Economics Jg. 29 (2020) Nr. S1, S. 63 - 82Online Volltext: dx.doi.org/ (Open Access)
-
Ambulant-sensitive Krankenhausfälle in Deutschland : Abgrenzung, Prävalenz und KostenIn: Gesundheitsökonomie & Qualitätsmanagement Jg. 24 (2019) Nr. 6, S. 277 - 291Online Volltext: dx.doi.org/
-
Improving Service Provision : The Health Care Services’PerspectiveIn: Journal of Service Management Research (SMR) Jg. 3 (2019) Nr. 4, S. 163 - 183Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
-
Service quality and perceived customer value in community pharmaciesIn: Health Services Management Research Jg. 23 (2019) Nr. 1, S. 36 - 48Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Stakeholder Participation in Regulatory Decision-MakingIn: Academy of Management Proceedings Jg. 2018 (2018) Nr. 1, S. 11748Online Volltext: dx.doi.org/
-
The impact of physician-level drug budgets on prescribing behaviorIn: The European Journal of Health Economics Jg. 19 (2018) Nr. 2, S. 213 - 222Online Volltext: dx.doi.org/
-
Dispensing behaviour of pharmacies in prescription drug marketsIn: Health policy: education, health service delivery and regulation Jg. 120 (2016) Nr. 2, S. 190 - 197Online Volltext: dx.doi.org/
-
Drug safety and the impact of drug warnings : An interrupted time series analysis of diabetes drug prescriptions in Germany and DenmarkIn: Health Policy Jg. 120 (2016) Nr. 12, S. 1404 - 1411Online Volltext: dx.doi.org/
-
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and AustraliaIn: Health policy Jg. 120 (2016) Nr. 10, S. 1115 - 1122Online Volltext: dx.doi.org/ (Open Access)
-
The diffusion of generics after patent expiry in GermanyIn: The European Journal of Health Economics Jg. 17 (2016) Nr. 8, S. 1027 - 1040Online Volltext: dx.doi.org/
-
Early benefit assessment of pharmaceuticals in Germany: Manufacturers' expectations versus the Federal Joint Committee's decisionsIn: Medical decision making (MDM) Jg. 34 (2014) Nr. 8, S. 1030 - 1047Online Volltext: dx.doi.org/
-
Funding decisions for newborn screening: A comparative review of 22 decision processes in EuropeIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 11 (2014) Nr. 5, S. 5403 - 5430Online Volltext: dx.doi.org/ (Open Access)
-
Ansätze zur empirischen Analyse von Entscheidungen über die Erstattungsfähigkeit von Gesundheitstechnologien in industrialisierten LändernIn: Recht und Politik im Gesundheitswesen: RPG Jg. 19 (2013) Nr. 3, S. 67 - 81
-
Link between process and appraisal in coverage decisions: An analysis with structural equation modelingIn: Medical decision making (MDM) Jg. 33 (2013) Nr. 8, S. 1009 - 1025Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Transparency vs. closed-door policy : Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysisIn: Health Policy Jg. 112 (2013) Nr. 3, S. 187 - 196Online Volltext: dx.doi.org/
-
A systematic review of coverage decision-making on health technologies : Evidence from the real worldIn: Health Policy Jg. 107 (2012) Nr. 2-3, S. 218 - 230Online Volltext: dx.doi.org/
-
Decision-making in healthcare: A practical application of partial least square path modelling to coverage of newborn screening programmesIn: BMC Medical Informatics and Decision Making Jg. 12 (2012) Nr. 1,Online Volltext: dx.doi.org/ (Open Access)
-
A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and preventionIn: Health Policy Jg. 101 (2011) Nr. 3, S. 290 - 299Online Volltext: dx.doi.org/
-
The role of health technology assessment in coverage decisions on newborn screeningIn: International Journal of Technology Assessment in Health Care Jg. 27 (2011) Nr. 4, S. 313 - 321Online Volltext: dx.doi.org/
-
Analysing coverage decision-making : Opening Pandora’s box?In: The European Journal of Health Economics Jg. 15 (2014) Nr. 9, S. 899 - 906Online Volltext: dx.doi.org/
-
Information on product quality, change agency and product adoptionIn: Academy of Management Proceedings Jg. 2017 (2017) Nr. 1, S. 13580Online Volltext: dx.doi.org/
-
A concise guide to reproducible research using secondary data(2022)Online Volltext; Online Volltext (Open Access)
-
A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations : Evidence from Preferred Drug Policies in Germany(2021)
(CINCH working paper series ; 2021/08)Online Volltext: dx.doi.org/ Online Volltext (Open Access)